Apoptosis is a distinctive form of cell death exhibiting specific morphological and biochemical characteristics, including cell membrane blebbing, chromatin condensation, genomic DNA fragmentation, and exposure of specific phagocytosis signaling molecules on the cell surface. Cells undergoing apoptosis differ from those dying through necrosis. Necrotic cells are usually recognized by the immune system as a danger signal and, thus, resulting in inflammation; in contrast, apoptotic death is quiet and orderly.
There are two major pathways of apoptotic cell death induction: The intrinsic pathway, also called the Bcl-2-regulated or mitochondrial pathway, is activated by various developmental cues or cytotoxic insults, such as viral infection, DNA damage and growth-factor deprivation, and is strictly controlled by the BCL-2 family of proteins. The extrinsic or death-receptor pathway is triggered by ligation of death receptors (members of the tumor necrosis factor (TNF) receptor family, such as Fas or TNF receptor-1 (TNFR1)) that contain an intracellular death domain, which can recruit and activate caspase-8 through the adaptor protein Fas-associated death domain (FADD; also known as MORT1) at the cell surface. This recruitment causes subsequent activation of downstream (effector) caspases, such as caspase-3, -6 or -7, without any involvement of the BCL-2 family.
Studies suggest that alterations in cell survival contribute to the pathogenesis of a number of human diseases, including cancer, viral infections, autoimmune diseases, neurodegenerative disorders, and AIDS (acquired immunodeficiency syndrome). Treatments designed to specifically alter the apoptotic threshold may have the potential to change the natural progression of some of these diseases.
Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
KM3455 |
dBET6
dBET6 是一种高效的,选择性的,细胞透过的,由Cereblon配体和BET配体相连的PROTAC,IC50 值为 14 nM,具有抗肿瘤活性。 |
1950634-92-0 | 98% |
![]() |
KM9260 |
DC260126
DC260126 是一种有效的 GPR40 (FFAR1) 拮抗剂。DC260126 剂量依赖性地抑制亚油酸、油酸、棕榈油酸和月桂酸刺激的 GPR40 介导的 Ca2+ 升高 (IC50 分别 6.28, 5.96, 7.07, 4.58 μM)。DC260126 对棕榈酸酯诱导的内质网应激和凋亡 (apoptosis) 有保护作用。 |
346692-04-4 | 98% |
![]() |
KM6373 |
DC661
DC661 是一种有效的棕榈酰蛋白硫酯酶 1 (PPT1) 抑制剂,抑制自噬 (autophagy),并作为抗溶酶体剂。具有抗肿瘤活性。 |
1872387-43-3 | ≥95% |
![]() |
KM9428 |
DC_AC50
DC_AC50 是 Atox1 和 CCS (铜伴侣蛋白) 的双抑制剂。抑制细胞内铜伴侣可作为减少/防止获得性化疗耐药的一种策略。 |
497061-48-0 | 98% |
![]() |
KM11183 |
DCH36_06
DCH36_06 是一种有效的选择性 p300/CBP 抑制剂,对 p300 和 CBP 的 IC50 分别为 0.6 μM 和 3.2 μM。DCH36_06 介导的 p300/CBP 抑制导致白血病细胞中 H3K18 的低乙酰化。抗肿瘤活性。 |
593273-05-3 | 98% |
![]() |
KM8425 |
DCZ0415
DCZ0415 是一种有效的 TRIP13 抑制剂,可损害非同源末端连接修复并抑制 NF-κB 活性。DCZ0415 在体外,体内以及在耐药性骨髓瘤患者衍生的原代细胞中诱导抗骨髓瘤活性。 |
2242470-43-3 | 98% |
![]() |
KM18061 |
Decitabine
Decitabine (5-Aza-2'-deoxycytidine) 是一种具有口服活性的脱氧胞苷类似物抗代谢物 (deoxycytidine analogue antimetabolite) 和 DNA 甲基转移酶 (DNA methyltransferase) 抑制剂。Decitabine 代替 DNA 掺入胞嘧啶可以将 DNA 甲基转移酶共价捕获到 DNA 中,从而导致对该酶的不可逆抑制。Decitabine 诱导细胞 G2/M 阻滞和细胞凋亡 (apoptosis),并具有有效的抗癌活性。 |
2353-33-5 | 98% |
![]() |
KM13193 |
Decursin
Decursin ((+)-Decursin) 是一种细胞毒性剂,是一种来自 Angelica gigas 根的有效蛋白激酶 C (protein kinase C) 激活剂。Decursin 通过下调 CXCR7 表达来抑制胃癌中的肿瘤生长,迁移和侵袭。Decursin 通过 Hippo/YAP 信号通路抑制 HepG2 细胞的生长。 |
5928-25-6 | 98% |
![]() |
KM6882 |
Degrasyn
Degrasyn (WP1130) 是可渗透细胞的 去泛素化酶(DUB) 抑制剂,直接抑制USP9x,USP5,USP14和UCH37的DUB活性。 Degrasyn 减弱抗细胞凋亡蛋白 Bcr-Abl 和 JAK2。 |
856243-80-6 | 98% |
![]() |
KM8857 |
Deguelin
Deguelin 是一种天然存在的鱼藤酮类化合物,通过阻止多种途径 (如 PI3K-Akt,IKK-NF-κB 和 MAPK-mTOR-survivin 等) 充当化学预防剂。Deguelin 与 Hsp90 的结合导致许多致癌蛋白 (包括 MEK1/2,Akt,HIF1α,COX-2 和 NF-κB) 的表达降低。。 |
522-17-8 | 98% |
![]() |
KM17785 |
Dehydroeffusol
Dehydroeffusol 是一种来自草药 Juncus effuses 的菲。Dehydroeffusol 通过选择性诱导肿瘤抑制性内质网应激和中度凋亡来抑制胃癌细胞生长和致瘤性。Dehydroeffusol 显示出非常低的毒性。 |
137319-34-7 |
![]() |
|
KM14665 |
Dehydrotrametenolic acid
Dehydrotrametenolic acid 是从茯苓 (Poria cocos) 的菌核中分离的甾醇。Dehydrotrametenolic acid 通过 caspase-3 途径诱导细胞凋亡。Dehydrotrametenolic acid 具有抗肿瘤活性,抗炎,抗糖尿病作用。 |
6879-05-6 | 98% |
![]() |
KM19022 |
DEL-22379
DEL-22379 是一种 ERK 二聚化抑制剂。DEL-22379 易与 ERK2 结合,Kd 为低微摩尔水平,即使在低纳摩尔浓度下也可检测到 EL-22379 与 ERK2 结合。DEL-22379 抑制 ERK2 二聚化,IC50 约为 0.5 μM。 |
181223-80-3 | 98% |
![]() |
KM6326 |
Delanzomib
Delanzomib (CEP-18770) 是一种强效的具有口服活性的蛋白酶体的胰凝乳蛋白酶样活性 (chymotrypsin-like activity of the proteasome) 抑制剂,IC50 为 3.8 nM。Delanzomib 抑制 NF-κB 活性,诱导癌细胞凋亡 (apoptotic),并具有很强的抗血管生成和抗癌活性。 |
847499-27-8 | ≥98% |
![]() |
KM9564 |
Delphinidin 3-glucoside chloride
Delphinidin 3-glucoside chloride (Delphinidin 3-O-glucoside chloride) 是在欧洲越橘提取物中发现的一种活性花色苷。Delphinidin 3-glucoside chloride 诱导 B 细胞慢性淋巴细胞性白血病 (B CLL) 的促凋亡作用。Delphinidin 3-glucoside chloride 通过结合 ERβ 发挥植物雌激素活性,IC50 为 9.7 μM。Delphinidin-3-O-glucoside chloride 抑制 EGFR,IC50 为 2.37 µM。 |
6906-38-3 | 98% |
![]() |
KM13345 |
Delphinidin chloride
Delphinidin chloride 是一种可从浆果和红酒中分离得到的花青素。Delphinidin chloride 表现出内皮依赖性血管舒张作用。Delphinidin chloride 还可以调节 JAK/STAT3 和 MAPKinase 信号传导,从而诱导 HCT116 细胞凋亡。 |
528-53-0 | ≥98% |
![]() |
KM13225 |
Demethoxycurcumin
脱甲氧姜黄素(Demethoxycurcumin)是姜黄素的一种主要活性成分,已被证明有抗炎症和对癌细胞毒性作用。 |
22608-11-3 | 98% |
![]() |
KM18814 |
Demethylzeylasteral
Demethylzeylasteral 是从雷公藤中分离出的一种三萜烯化合物,具有抗炎、免疫抑制和抗肿瘤活性。Demethylzeylasteral 能显著减轻动脉粥样硬化 (AS)。Demethylzeylasteral 通过阻断 TGF-β 信号通路,抑制三阴性乳腺癌的侵袭。 |
107316-88-1 | 98% |
![]() |
KM14799 |
Deoxypodophyllotoxin
Deoxypodophyllotoxin (DPT),鬼臼毒素的衍生物,是一种木酚素,从 Sinopodophullumhexandrum (小檗科)的根茎分离,具有强效抗有丝分裂和抗病毒特性。Deoxypodophyllotoxin 作为靶向微管的药物,不仅抗有丝分裂剂而且作为有效的血管生成抑制剂,在肿瘤学中具有重大影响。Deoxypodophyllotoxin 诱导细胞自噬 (autophagy) 和细胞凋亡 (apoptosis)。 Deoxypodophyllotoxin 引起 DRG 神经元细胞内 Ca2+ 浓度增加。 |
19186-35-7 | 98% |
![]() |
KM16118 |
Deracoxib
Deracoxib是COX-2选择性抑制剂,非甾体抗炎化合物。 |
169590-41-4 | 98% |
![]() |